OBJECTIVES: Evidence suggests inflammation is associated with cognitive impairment, but previous epidemiological studies have reported conflicting results. DESIGN: Prospective population-based cohort. SETTING: Epidemiology of Hearing Loss Study participants. PARTICIPANTS: Individuals without cognitive impairment in 1998-2000 (N = 2,422; 1,947 with necessary data). MEASUREMENTS: Cognitive impairment (Mini-Mental State Examination score <24 or diagnosis of dementia) was ascertained in 1998-2000, 2003-2005, and 2009-2010. Serum C-reactive protein (CRP) and interleukin-6 (IL-6) were measured in 1988-1990, 1998-2000, and 2009-2010; tumor necrosis factor-alpha was measured from 1998-2000. RESULTS: Participants with high CRP in 1988-1990 and 1998-2000 had lower risk of cognitive impairment than those with low CRP at both time points (hazard ratio (HR) = 0.46, 95% confidence interval (CI) = 0.26-0.80). Risk did not differ according to 10-year IL-6 profile or baseline inflammation category in the whole cohort. In sensitivity analyses restricted to statin nonusers, those with high IL-6 at both times had greater risk of cognitive impairment than those with low IL-6 at both times (HR = 3.35, 95% CI = 1.09-10.30). In secondary analyses, each doubling of IL-6 change over 20 years was associated with greater odds of cognitive impairment in 2009-2010 in the whole cohort (odds ratio (OR) = 1.40, 95% CI = 1.04-1.89), whereas a doubling of CRP change over 20 years was associated with cognitive impairment only in statin nonusers (OR = 1.32, 95% CI = 1.06-1.65). CONCLUSION: With data collected over 20 years, this study demonstrated greater likelihood of cognitive impairment in individuals with repeated high or increasing IL-6. The inconsistent CRP findings may reflect effects of statin medications, survival effects, or adverse effects associated with chronically low CRP. Further studies of long-term inflammation and cognitive impairment are needed.
OBJECTIVES: Evidence suggests inflammation is associated with cognitive impairment, but previous epidemiological studies have reported conflicting results. DESIGN: Prospective population-based cohort. SETTING: Epidemiology of Hearing Loss Study participants. PARTICIPANTS: Individuals without cognitive impairment in 1998-2000 (N = 2,422; 1,947 with necessary data). MEASUREMENTS: Cognitive impairment (Mini-Mental State Examination score <24 or diagnosis of dementia) was ascertained in 1998-2000, 2003-2005, and 2009-2010. Serum C-reactive protein (CRP) and interleukin-6 (IL-6) were measured in 1988-1990, 1998-2000, and 2009-2010; tumor necrosis factor-alpha was measured from 1998-2000. RESULTS:Participants with high CRP in 1988-1990 and 1998-2000 had lower risk of cognitive impairment than those with low CRP at both time points (hazard ratio (HR) = 0.46, 95% confidence interval (CI) = 0.26-0.80). Risk did not differ according to 10-year IL-6 profile or baseline inflammation category in the whole cohort. In sensitivity analyses restricted to statin nonusers, those with high IL-6 at both times had greater risk of cognitive impairment than those with low IL-6 at both times (HR = 3.35, 95% CI = 1.09-10.30). In secondary analyses, each doubling of IL-6 change over 20 years was associated with greater odds of cognitive impairment in 2009-2010 in the whole cohort (odds ratio (OR) = 1.40, 95% CI = 1.04-1.89), whereas a doubling of CRP change over 20 years was associated with cognitive impairment only in statin nonusers (OR = 1.32, 95% CI = 1.06-1.65). CONCLUSION: With data collected over 20 years, this study demonstrated greater likelihood of cognitive impairment in individuals with repeated high or increasing IL-6. The inconsistent CRP findings may reflect effects of statin medications, survival effects, or adverse effects associated with chronically low CRP. Further studies of long-term inflammation and cognitive impairment are needed.
Authors: Scott D Nash; Karen J Cruickshanks; Ronald Klein; Barbara E K Klein; F Javier Nieto; Rick Chappell; Carla R Schubert; Michael Y Tsai Journal: J Am Geriatr Soc Date: 2013-07-26 Impact factor: 5.562
Authors: Nancy S Jenny; Benjamin French; Alice M Arnold; Elsa S Strotmeyer; Mary Cushman; Paulo H M Chaves; Jingzhong Ding; Linda P Fried; Stephen B Kritchevsky; Dena E Rifkin; Mark J Sarnak; Anne B Newman Journal: J Gerontol A Biol Sci Med Sci Date: 2012-02-24 Impact factor: 6.053
Authors: E Tarkowski; L Rosengren; C Blomstrand; C Wikkelsö; C Jensen; S Ekholm; A Tarkowski Journal: Clin Exp Immunol Date: 1997-12 Impact factor: 4.330
Authors: Karen J Cruickshanks; David M Nondahl; Ted S Tweed; Terry L Wiley; Barbara E K Klein; Ronald Klein; Rick Chappell; Dayna S Dalton; Scott D Nash Journal: Hear Res Date: 2009-10-22 Impact factor: 3.208
Authors: Carla R Schubert; Mary E Fischer; A Alex Pinto; Yanjun Chen; Barbara E K Klein; Ronald Klein; Michael Y Tsai; Ted S Tweed; Karen J Cruickshanks Journal: J Am Geriatr Soc Date: 2019-04-01 Impact factor: 5.562
Authors: Natascha Merten; Adam J Paulsen; A Alex Pinto; Yanjun Chen; Lauren K Dillard; Mary E Fischer; Guan-Hua Huang; Barbara E K Klein; Carla R Schubert; Karen J Cruickshanks Journal: J Gerontol A Biol Sci Med Sci Date: 2020-09-16 Impact factor: 6.053
Authors: Margarete A Wichmann; Karen J Cruickshanks; Cynthia M Carlsson; Rick Chappell; Mary E Fischer; Barbara E K Klein; Ronald Klein; Carla R Schubert Journal: Alzheimer Dis Assoc Disord Date: 2016 Apr-Jun Impact factor: 2.703
Authors: Brandon S Klinedinst; Colleen Pappas; Scott Le; Shan Yu; Qian Wang; Li Wang; Karin Allenspach-Jorn; Jonathan P Mochel; Auriel A Willette Journal: Brain Behav Immun Date: 2019-09-09 Impact factor: 7.217
Authors: Rebecca K West; Ramit Ravona-Springer; Anthony Heymann; James Schmeidler; Derek Leroith; Keren Koifman; Ryan C N D'Arcy; Xiaowei Song; Elizabeth Guerrero-Berroa; Rachel Preiss; Hadas Hoffman; Mary Sano; Jeremy M Silverman; Michal Schnaider-Beeri Journal: Alzheimers Dement Date: 2016-05-02 Impact factor: 21.566
Authors: Heather S McKay; Jay H Bream; Joseph B Margolick; Otoniel Martínez-Maza; John P Phair; Charles R Rinaldo; Alison G Abraham; Lisa P Jacobson Journal: Cytokine Date: 2016-06-10 Impact factor: 3.861
Authors: Adam J Paulsen; Carla R Schubert; Alex Pinto; Cynthia M Carlsson; Richard J Chappell; Mary E Fischer; Barbara E K Klein; Ronald Klein; Michael Y Tsai; Karen J Cruickshanks Journal: Alzheimer Dis Assoc Disord Date: 2020 Jan-Mar Impact factor: 2.703